Join
Live feed
·
PRReleasevia Quantisnow
AbbVie Inc. logo
ImmunoGen Inc. logo

AbbVie to Acquire ImmunoGen, including its Flagship Cancer Therapy ELAHERE® (mirvetuximab soravtansine-gynx), Expanding Solid Tumor Portfolio

ByQuantisnow·Wall Street's wire, on your screen.
ABBV· AbbVie Inc.IMGN· ImmunoGen Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ABBV (AbbVie Inc.), IMGN (ImmunoGen Inc.) and more on Quantisnow.